Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Finished Goods (2024)

Whitehawk Therapeutics (WHWK) has disclosed Finished Goods for 1 consecutive years, with $1.8 million as the latest value for Q4 2024.

  • Quarterly Finished Goods changed N/A to $1.8 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2024, changed N/A year-over-year, with the annual reading at $1.8 million for FY2024, N/A changed from the prior year.
  • Finished Goods for Q4 2024 was $1.8 million at Whitehawk Therapeutics.
  • The five-year high for Finished Goods was $1.8 million in Q4 2024, with the low at $1.8 million in Q4 2024.